These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3374780

  • 21. Bevacizumab is active as a single agent against recurrent malignant gliomas.
    Agha CA, Ibrahim S, Hassan A, Elias DA, Fathallah-Shaykh HM.
    Anticancer Res; 2010 Feb; 30(2):609-11. PubMed ID: 20332478
    [Abstract] [Full Text] [Related]

  • 22. Chemotherapy of recurrent pediatric posterior fossa tumors.
    Edwards MS, Levin VA, Wilson CB.
    Clin Neurosurg; 1983 Feb; 30():209-25. PubMed ID: 6667576
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
    [Abstract] [Full Text] [Related]

  • 28. [Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors].
    Hildebrand JG.
    Rev Neurol (Paris); 1992 Aug; 148(6-7):435-40. PubMed ID: 1448663
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan.
    Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, Fisher MJ, Cohen B.
    Pediatr Blood Cancer; 2009 Jul; 52(7):791-5. PubMed ID: 19165892
    [Abstract] [Full Text] [Related]

  • 32. Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study.
    Balmaceda C, Fetell MR, Hesdorffer C.
    Cancer Chemother Pharmacol; 1997 Jul; 40(1):72-4. PubMed ID: 9137533
    [Abstract] [Full Text] [Related]

  • 33. Brachytherapy of brain tumors.
    Sneed PK, Gutin PH, Prados MD, Phillips TL, Weaver KA, Wara WM, Larson DA.
    Stereotact Funct Neurosurg; 1992 Jul; 59(1-4):157-65. PubMed ID: 1338231
    [Abstract] [Full Text] [Related]

  • 34. Second temporal remission in a malignant glioma with trofosfamide and etoposide: a case report.
    Wolff JE, Boos J, Krähling KH, Jürgens H.
    Klin Padiatr; 1996 Jul; 208(4):190-2. PubMed ID: 8776706
    [Abstract] [Full Text] [Related]

  • 35. Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine.
    Heiland DH, Masalha W, Franco P, Machein MR, Weyerbrock A.
    J Neurooncol; 2016 Feb; 126(3):567-75. PubMed ID: 26614518
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.
    Kaloshi G, Roci E, Rroji A, Ducray F, Petrela M.
    J Neurosurg; 2015 Nov; 123(5):1244-6. PubMed ID: 26115464
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P, Litzow M, Buckner J, Arndt C, Moynihan T, Christianson T, Ansell S, Galanis E.
    Cancer; 2008 Apr 15; 112(8):1805-11. PubMed ID: 18300237
    [Abstract] [Full Text] [Related]

  • 40. Response and progression in recurrent malignant glioma.
    Hess KR, Wong ET, Jaeckle KA, Kyritsis AP, Levin VA, Prados MD, Yung WK.
    Neuro Oncol; 1999 Oct 15; 1(4):282-8. PubMed ID: 11550320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.